Section 9: Gynecologic and Obstetric Disorders
Which of the following drug properties limits the ability of a drug to readily transfer across the placenta:
B. Molecular weight below 500 daltons
Which of the following types of data to evaluate drug safety during pregnancy is least likely to be available?
A. Case study or case series
C. Retrospective cohort study
D. Randomized, controlled trial
A 36-year-old woman with an active seizure disorder is contemplating pregnancy. Your recommendation to her is:
A. Switch antiepileptic treatment to a medication not known to cause neural tube defects
B. Take folic acid 4 mg daily during the first trimester
C. Take folic acid 4 mg daily before conception followed by 4 mg daily during at least the first trimester
D. Increase dietary intake of folic acid
A 29-year-old woman who is at week 37 is complaining of constipation for the past 3 days despite increasing her dietary fiber and water intake. Which of the following recommendations is not appropriate?
E. None of the above is appropriate
Which of the following interventions decreases the risk of developing preeclampsia during pregnancy in women at risk for preeclampsia?
C. Oral calcium supplementation
E. Intravenous magnesium sulfate infusion
For a woman at 34 weeks of gestation with an acute deep vein thrombosis, the treatment of choice is: